Primary record
1-[2-[4-(Diethylamino)butylamino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]urea
- 库存
- 3,937 克
- 纯度
- 99.3 %
- CAS
- 219580-11-7
化合物标识与属性
- CAS
- 219580-11-7
- PubChem CID
- 1401
- SMILES
- CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C
- Canonical SMILES
- CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1
名称与同义词
- PD173074
- 219580-11-7
- PD 173074
- PD-173074
- 2fgi
- FGFR inhibitors
- RefChem:858793
- A4TLL8634Y
- DXCUKNQANPLTEJ-UHFFFAOYSA-N
- 1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea
- D0VF6E
- AC1L1BE8
- CHEMBL189584
- UNII-A4TLL8634Y
- MFCD08705327
- JSPY-st000263
- cc-523
- CHEBI:63448
- MLS001074892
- MLS006011101
- SCHEMBL177946
- DTXSID30176363
- Pyrido[2,3-d]pyrimidine 12
- AC1Q5L34
- BDBM6190
- C28H41N7O3
- GTPL5037
- orb1305225
- DTXCID9098854
- PD-173074-d9
- SCHEMBL29828472
- CTK4E8045
- AOB2517
- CID1401
- EX-A197
- SYN1176
- BCPP000121
- GLXC-04620
- HMS2233G17
- HMS3265E09
- HMS3265E10
- HMS3265F09
- HMS3265F10
- HMS3371E08
- HMS3648A10
- HMS3654L09
- BCP02368
- CID:1401
- KS-00000PL5
- UWC97929
- ZINC3870533
- ABP000888
- AN-324
- ANW-73236
- AR-1C5653
- EBC-11310
- HB3584
- NSC766908
- PX-478
- s1264
- PD-0173074
- AKOS016008595
- BCP9001065
- BLP-012509
- CCG-264881
- CS-0182
- NSC-766908
- QC-7737
- RL02670
- SB19382
- SDCCGSBI-0647583.P003
- 1-tert-butyl-3-[2-[4-(diethylamino)butylamino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea
- NCGC00165863-01
- NCGC00165863-02
- NCGC00165863-17
- PD-173074-[d9]
- 4CA-0978
- AC-24850
- AJ-46337
- AK105355
- AS-16310
- BC659951
- BP162784
- HY-10321
- PD-173074 D9
- SC-90094
- SID:53790840
- SMR000568412
- AB0033759
- RT-012706
- ST2403291
- A8253
- FGF/VEGF Receptor Tyrosine Kinase Inhibitor
- FT-0673540
- P2474
- PD-173074?
- SW218104-2
- X7486
- FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074
- J1.019.452K
- PD 173074, >=96% (HPLC), powder
- A10703
- A25450
- W-5382
- 1-tert-butyl-3-[2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea
- 1794979-29-5
- PD173074/PD-173074/
- C115711
- SR-01000837541
- 3-tert-butyl-1-(2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea
- SR-01000837541-2
- BRD-K97764662-001-17-3
- BRD-K97764662-001-20-7
- Q27088276
- Z2036684790
- B2693-263525
- 1-tert-butyl-3-(2-(4-(diethylamino)butylamino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea
- 1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea
- PD173074, 219580-11-7
- 1-t-Butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)-pyrido[2,3-d]pyrimidin-7-yl)urea
- N-(2-((4-(DIETHYLAMINO)BUTYL)AMINO)-6-(3,5-DIMETHOXYPHENYL)PYRIDO(2,3-D)PYRIMIDIN-7-YL)-N'-(1,1-DIMETHYLETHYL)UREA
- N-[2-[[4-(Diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea
- PD1
- FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074 - CAS 219580-11-7
- 1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-y
- 1-(tert-Butyl)-3-[7-[[4-(diethylamino)butyl]amino]-3-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-2-yl]urea
- 1-[2-[4-(Diethylamino)butylamino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]urea
- 1-tert-butyl-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido(2,3-d)pyrimidin-7-yl)urea
- 1-tert-Butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)urea
- 1-tert-butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)ureea
- 114560-48-4
- 22454-96-2
- 633-614-8
- 685898-44-6
- N-(tert-Butyl)-N -[2-[[4-(diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea
- N-[2-[[4-(Diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea
- N-[2-[[4-(Diethylamino)butyl]amino] -6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-y l]-N'-(1,1-dimethylethyl)urea
- N-[2-[[4-(Diethylamino)butyl]amino]-6-(3,5- dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1- dimethylethyl)urea
- N-[2-[[4-(diethylaMino)butyl]aMino]-6-(3,5-diMethoxyphenyl)pyrido[2,3-d ]pyriMidin-7-yl]-N'-(1,1-diMethylethyl)UREA
- N-[2-[[4-(diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-urea
- N-tert-Butyl-N'-[2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea
- PD 173074;n-[2-[[4-(diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-n'-(1,1-dimethylethyl)urea
- UREA, N-(2-((4-(DIETHYLAMINO)BUTYL)AMINO)-6-(3,5-DIMETHOXYPHENYL)PYRIDO(2,3-D)PYRIMIDIN-7-YL)-N'-(1,1-DIMETHYLETHYL)-